Collegium Pharmaceutical, Inc. COLL Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s total cost of revenue?
- Collegium Pharmaceutical, Inc. (COLL) reported total cost of revenue of $76.27M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s total cost of revenue changed year-over-year?
- Collegium Pharmaceutical, Inc.'s total cost of revenue decreased by 5.2% year-over-year, from $80.43M to $76.27M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s total cost of revenue has grown at a 25.9% compound annual growth rate (CAGR), from $126.25M to $317.31M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.